These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22158332)

  • 21. Genetic ancestry plays a central role in population pharmacogenomics.
    Yang HC; Chen CW; Lin YT; Chu SK
    Commun Biol; 2021 Feb; 4(1):171. PubMed ID: 33547344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics of drug transporters in the enterohepatic circulation.
    Stieger B; Meier PJ
    Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research.
    Daud ANA; Bergsma EL; Bergman JEH; De Walle HEK; Kerstjens-Frederikse WS; Bijker BJ; Hak E; Wilffert B
    BMC Pregnancy Childbirth; 2017 Apr; 17(1):120. PubMed ID: 28410576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ancillary risk information and pharmacogenetic tests: social and policy implications.
    Henrikson NB; Burke W; Veenstra DL
    Pharmacogenomics J; 2008 Apr; 8(2):85-9. PubMed ID: 17486108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodological quality of pharmacogenetic studies: issues of concern.
    Jorgensen AL; Williamson PR
    Stat Med; 2008 Dec; 27(30):6547-69. PubMed ID: 18837075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using multiple drug exposure levels to optimize power in pharmacogenetic trials.
    Judson R
    J Clin Pharmacol; 2003 Aug; 43(8):816-24. PubMed ID: 12953338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.
    Lu M; Lewis CM; Traylor M
    BMC Med Genomics; 2017 Jun; 10(1):47. PubMed ID: 28629370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conference Scene: The great debate: genome-wide association studies in pharmacogenetics research, good or bad?
    Bailey KR; Cheng C
    Pharmacogenomics; 2010 Mar; 11(3):305-8. PubMed ID: 20235786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using germline genotype in cancer pharmacogenetic studies.
    McWhinney SR; McLeod HL
    Pharmacogenomics; 2009 Mar; 10(3):489-93. PubMed ID: 19650256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and implementation of a pharmacist-managed clinical pharmacogenetics service.
    Crews KR; Cross SJ; McCormick JN; Baker DK; Molinelli AR; Mullins R; Relling MV; Hoffman JM
    Am J Health Syst Pharm; 2011 Jan; 68(2):143-50. PubMed ID: 21200062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADME pharmacogenetics: current practices and future outlook.
    Grossman I
    Expert Opin Drug Metab Toxicol; 2009 May; 5(5):449-62. PubMed ID: 19416082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A question-based approach to adopting pharmacogenetics to understand risk for clinical variability in pharmacokinetics in early drug development.
    Evers R; Blanchard RL; Warner AW; Cutler D; Agrawal NG; Shaw PM
    Clin Pharmacol Ther; 2014 Sep; 96(3):291-5. PubMed ID: 25141952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The missing linkage: what pharmacogenetic associations are left to find in CYP3A?
    Perera MA
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):17-28. PubMed ID: 19968573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
    Lubomirov R; di Iulio J; Fayet A; Colombo S; Martinez R; Marzolini C; Furrer H; Vernazza P; Calmy A; Cavassini M; Ledergerber B; Rentsch K; Descombes P; Buclin T; Decosterd LA; Csajka C; Telenti A;
    Pharmacogenet Genomics; 2010 Apr; 20(4):217-30. PubMed ID: 20139798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
    Shah RR
    Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trick or treat: the effect of placebo on the power of pharmacogenetic association studies.
    Singer C; Grossman I; Avidan N; Beckmann JS; Pe'er I
    Hum Genomics; 2005 Mar; 2(1):28-38. PubMed ID: 15814066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
    Solhaug V; Molden E
    Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample.
    Lunenburg CATC; Thirstrup JP; Bybjerg-Grauholm J; Bækvad-Hansen M; Hougaard DM; Nordentoft M; Werge T; Børglum AD; Mors O; Mortensen PB; Gasse C
    Transl Psychiatry; 2021 May; 11(1):294. PubMed ID: 34006849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.
    Johnson JA; Lima JJ
    Pharmacogenetics; 2003 Sep; 13(9):525-34. PubMed ID: 12972951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized medicine: is it a pharmacogenetic mirage?
    Shah RR; Shah DR
    Br J Clin Pharmacol; 2012 Oct; 74(4):698-721. PubMed ID: 22591598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.